- Premier Partners, Samsung Venture Investment Corp., and Redbadge Pacific join investment round
- Pioneering the market for disease-specific dietary solutions with Medi 바카라 에볼루션 and Care 바카라 에볼루션
- Driving innovation of AI-based dietary algorithm and digital nutritional intervention platform, ‘ARCHEN.X’

바카라 에볼루션

[by Kang, In Hyo] MEDI.SOLA, a company specializing in customized food care solutions, announced on April 3 that it has successfully secured KRW 13 billion (approximately USD 8.8 million) in Series A funding. Key investors in this round included Premier Partners, Samsung Venture Investment, and Redbadge Pacific. According to the company, the investment reflects a strong evaluation of MEDI.SOLA's technological capabilities and growth potential by the participating investors.

MEDI.바카라 에볼루션 is a food tech company founded in December 2021 by CEO Lee Seung-yeon and CEO Lee Don-gu. Lee Seung-yeon, formerly Vice President of S FOOD, played a key role in establishing and managing retail brands such as 'Johncook Deli Meats,' overseeing marketing, sales, and operations. Lee Don-gu, on the other hand, has extensive experience in the healthcare and biotechnology sectors, having led investment initiatives at KB Investment. In 2024, the company secured around KRW 2 billion in funding through a pre-Series A investment round.

MEDI.바카라 에볼루션 implements a ‘home-cooked-based food care’ system, offering two categories: ‘Food Care,’ designed for proactive health maintenance, and ‘Medi Food,’ which provides targeted nutritional support for individuals with specific health concerns. Through this model, the company aims to deliver sustainable health management solutions through food as a means of personalized care.

In addition, MEDI.바카라 에볼루션 is expanding beyond conventional healthy diets into the digital healthcare sector through ‘ARCHEN.X’, an AI-based healthcare platform currently under development. This initiative includes improvements in diet design algorithms, the identification of data-driven functional food ingredients, and the development of digital diet prescription technologies.

Notably, MEDI.바카라 에볼루션 has been conducting joint clinical intervention research with Severance Hospital for over six years, aiming to validate its solutions’ clinical efficacy in real-world patient settings. Through this research, the company is simultaneously strengthening its technological credibility and academic standing. The studies focus on diverse target groups, including patients with recurrent breast cancer, hyperlipidemia, and chronic kidney disease, and have resulting in the publication of SCI(E)-level papers. By leveraging this medical verification process, the company is establishing a high entry barrier in the dietary intervention market, distinguishing itself from competitors.

With the newly secured investment, MEDI.바카라 에볼루션 aims to accelerate its comprehensive business expansion across multiple areas, including enhancing AI-based diet design algorithms, expanding R&D on customized functional foods for specific diseases, scaling its food care platform through the integration of health data, and accelerating its entry into the B2B and B2C markets.

Co-CEO Lee Seung-yeon, who previously suffered from severe nutritional deficiencies and subsequently began researching the Korean 바카라 에볼루션terranean diet in collaboration with 바카라 에볼루션cal professionals and clinical nutritionists, stated, “The innovation of dietary habits focused on disease prevention and management through home-based re바카라 에볼루션es has become an inevitable trend.” Lee further emphasized, “Our goal is to create a future where everyone has equal access to essential nutrition, tailored to the specific dietary needs of Koreans.”

“MEDI.바카라 에볼루션 embodies the philosophy that ‘Food is Medicine’ by leveraging personal health information and nutritional data, with the goal of redefining food as a new form of treatment,” Co-CEO Lee Don-gu further highlighted. “With this investment, we aim to propel MEDI.바카라 에볼루션 into a leading global company in the customized food care industry.”

The Samsung Venture Investment reviewer who led this funding round remarked, “MEDI.바카라 에볼루션 has successfully integrated technology, data, and medicine, position itself as a ‘next-generation healthcare solution company’ that bridges the gap between food and medicine.” The reviewer further expressed, “We anticipate significant market expansion through its platform business and the development of functional foods in the future.”

MEDI.바카라 에볼루션 aims to contribute to disease prevention and the improvement of quality of life through science-based food care solutions that integrate medicine, nutrition, and information technology (IT). Additionally, the company plans to actively expand into the global market and strengthen strategic partnerships to accelerate its growth and impact.

저작권자 © 더바이오 무단전재 및 재배포 금지